Marsam recalls
Executive Summary
Schein subsidiary Marsam extends recall to all distributed products that have not expired. The company plans to resume production in the fourth quarter after a voluntary shutdown to address FDA observations in an ongoing inspection ("The Pink Sheet" June 21, p. 32). Schein will contract out manufacturing of a Marsam-produced cephalosporin antibiotic to satisfy demand until the end of the year